Pulse Biosciences Statistics
Share Statistics
Pulse Biosciences has 67.27M
shares outstanding. The number of shares has increased by 11.39%
in one year.
| Shares Outstanding | 67.27M |
| Shares Change (YoY) | 11.39% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 9.76% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 5,144 |
| FTD / Avg. Volume | 2.75% |
Short Selling Information
The latest short interest is 2.38M, so 3.54% of the outstanding
shares have been sold short.
| Short Interest | 2.38M |
| Short % of Shares Out | 3.54% |
| Short % of Float | 15.41% |
| Short Ratio (days to cover) | 15.45 |
Valuation Ratios
The PE ratio is -18.97 and the forward
PE ratio is -35.91.
Pulse Biosciences's PEG ratio is
-4.17.
| PE Ratio | -18.97 |
| Forward PE | -35.91 |
| PS Ratio | 0 |
| Forward PS | 33 |
| PB Ratio | 8.85 |
| P/FCF Ratio | -27.88 |
| PEG Ratio | -4.17 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Pulse Biosciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.88,
with a Debt / Equity ratio of 0.08.
| Current Ratio | 11.88 |
| Quick Ratio | 11.88 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | -0.17 |
| Debt / FCF | -0.24 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-714,466.67 |
| Employee Count | 75 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 48.64% in the
last 52 weeks. The beta is 1.6, so Pulse Biosciences's
price volatility has been higher than the market average.
| Beta | 1.6 |
| 52-Week Price Change | 48.64% |
| 50-Day Moving Average | 16.64 |
| 200-Day Moving Average | 17.87 |
| Relative Strength Index (RSI) | 49.05 |
| Average Volume (20 Days) | 186,920 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -56.26M |
| Net Income | -53.59M |
| EBITDA | -52.41M |
| EBIT | -53.59M |
| Earnings Per Share (EPS) | -0.92 |
Full Income StatementBalance Sheet
The company has 118.04M in cash and 8.9M in
debt, giving a net cash position of 109.14M.
| Cash & Cash Equivalents | 118.04M |
| Total Debt | 8.9M |
| Net Cash | 109.14M |
| Retained Earnings | -390.5M |
| Total Assets | 133.38M |
| Working Capital | 113.15M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -36.34M
and capital expenditures -125K, giving a free cash flow of -36.47M.
| Operating Cash Flow | -36.34M |
| Capital Expenditures | -125K |
| Free Cash Flow | -36.47M |
| FCF Per Share | -0.62 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
